Author

L. Debande

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

B. S. Marteyn· 2 shared A. Andre· 1 shared A. C. Andre· 1 shared A. Milinski· 1 shared A. Sabbah· 1 shared B. Roche· 1 shared C. Allmang-Cura· 1 shared C. Ridley· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. S. Marteyn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SPATEs promote the survival of Shigella to the plasma complement system upon hemorrhage and bacteremia

L. Debande, A. Sabbah, L. Kuhn, P. Ngondo, A. C. Andre, B. Roche, M. Laborde, M.-V. Cantalapiedra-Mateo, T. Thahouly, A. Milinski, L. Bianchetti, C. Allmang-Cura, M. Frugier, B. S. Marteyn

This study shows Shigella survives plasma exposure via SPATEs, which cleave C3 to impair complement activation, enhancing virulence during bacteremia.

bioRxiv · Nov 8, 2023 · PreprintMicrobiology

Neutrophils degranulate GAG-containing proteoglycofili, which block Shigella growth and degrade virulence factors

A. Andre, M. V. Barroso, J. Skerniskyte, M. Siegwald, V. Paul, L. Debande, C. Ridley, I. Svahn, S. Rigaud, J.-Y. Tinevez, R. Vives, P. Sansonetti, B. S. Marteyn

This study shows that neutrophil degranulation releases PGF, which inhibit Shigella growth and degrade its virulence factors, and that hyaluronidase treatment disrupts PGF structure and antimicrobial activity.

bioRxiv · Feb 8, 2022 · PreprintImmunology